Necrobiotic xanthogranuloma treated with lenalidomide

Clin Exp Dermatol. 2018 Apr;43(3):345-347. doi: 10.1111/ced.13293. Epub 2017 Oct 19.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Aged
  • Angiogenesis Inhibitors / therapeutic use*
  • Dermatologic Agents / therapeutic use*
  • Female
  • Humans
  • Immunologic Factors / therapeutic use*
  • Lenalidomide
  • Necrobiotic Xanthogranuloma / drug therapy*
  • Necrobiotic Xanthogranuloma / pathology
  • Thalidomide / analogs & derivatives*
  • Thalidomide / therapeutic use

Substances

  • Angiogenesis Inhibitors
  • Dermatologic Agents
  • Immunologic Factors
  • Thalidomide
  • Lenalidomide